Supplementary Figure S7 from Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers

Supplemental figure 7. (A) Alluvial plot showing the correspondence between the Vancouver signatures (VS1-5) and the pan-cancer chromosomal instability signatures (CX1-17) for 185 samples from the Vancouver cohort; samples are assigned to a signature based on their maximum signature exposure (activity). (B) The per-sample exposure to signatures CX1-17, for the same 185 samples.